QP-5113

N/A

Report date: 2024/12/31 17:13:58

Base Information

Drug NameQP-5113
Drug Alias NameQP-5113QP5113
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVanilloid receptor modulators
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNanjing Delova Biotech Co LtdHainan Qingpu Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Qingpu Biotechnology Co LtdNanjing Delova Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A